Provident Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-726,333
| Closed | -$24M | – | 57 |
|
|
2019
Q2 | $24M | Buy |
726,333
+88,099
| +14% | +$2.92M | 3.56% | 16 |
|
|
2019
Q1 | $22.4M | Buy |
638,234
+74,730
| +13% | +$2.62M | 3.67% | 16 |
|
|
2018
Q4 | $18.7M | Sell |
563,504
-26,765
| -5% | -$889K | 3.34% | 16 |
|
|
2018
Q3 | $29.7M | Buy |
590,269
+47,075
| +9% | +$2.37M | 4.23% | 14 |
|
|
2018
Q2 | $32.5M | Buy |
543,194
+3,658
| +0.7% | +$219K | 4.61% | 7 |
|
|
2018
Q1 | $24.7M | Buy |
+539,536
| New | +$24.7M | 3.9% | 15 |
|